BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11605070)

  • 1. Mutational analysis of the PTEN/MMAC1 tumour suppressor gene in primary human malignant mesotheliomas.
    Papp T; Schipper H; Pemsel H; Unverricht M; Muller KM; Wiethege T; Schiffmann D; Rahman Q
    Oncol Rep; 2001; 8(6):1375-9. PubMed ID: 11605070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in advanced gastric carcinomas.
    Wang JY; Huang TJ; Chen FM; Hsieh MC; Lin SR; Hou MF; Hsieh JS
    Virchows Arch; 2003 May; 442(5):437-43. PubMed ID: 12695913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in hepatocellular carcinoma.
    Yeh KT; Chang JG; Chen YJ; Chen ST; Yu SY; Shih MC; Perng LI; Wang JC; Tsai M; Chang CP
    Cancer Invest; 2000; 18(2):123-9. PubMed ID: 10705874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 and PTEN/MMAC1 mutational analysis of the small-intestinal cancer.
    Ito K; Kubokawa M; Harada N; Mibu R; Nawata H
    Dig Liver Dis; 2003 May; 35(5):347-50. PubMed ID: 12846407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation analysis of the PTEN/MMAC1 gene in lung cancer.
    Forgacs E; Biesterveld EJ; Sekido Y; Fong K; Muneer S; Wistuba II; Milchgrub S; Brezinschek R; Virmani A; Gazdar AF; Minna JD
    Oncogene; 1998 Sep; 17(12):1557-65. PubMed ID: 9794233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of PTEN/MMAC1 alteration in neuroblastoma.
    Moritake H; Horii Y; Kuroda H; Sugimoto T
    Cancer Genet Cytogenet; 2001 Mar; 125(2):151-5. PubMed ID: 11369059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of the PTEN/MMAC1 gene locus in primary lung cancer with distant metastasis.
    Hosoya Y; Gemma A; Seike M; Kurimoto F; Uematsu K; Hibino S; Yoshimura A; Shibuya M; Kudoh S
    Lung Cancer; 1999 Aug; 25(2):87-93. PubMed ID: 10470842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in cervical cancer.
    Su TH; Chang JG; Perng LI; Chang CP; Wei HJ; Wang NM; Tsai CH
    Gynecol Oncol; 2000 Feb; 76(2):193-9. PubMed ID: 10637069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTEN/MMAC1 gene mutation is a rare event in soft tissue sarcomas without specific balanced translocations.
    Saito T; Oda Y; Kawaguchi K; Takahira T; Yamamoto H; Tamiya S; Tanaka K; Matsuda S; Sakamoto A; Iwamoto Y; Tsuneyoshi M
    Int J Cancer; 2003 Mar; 104(2):175-8. PubMed ID: 12569572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of new PTEN/MMAC1 mutations in head and neck squamous cell carcinomas with loss of chromosome 10.
    Poetsch M; Lorenz G; Kleist B
    Cancer Genet Cytogenet; 2002 Jan; 132(1):20-4. PubMed ID: 11801303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational analysis of the PTEN/MMAC1 gene in primary oesophageal squamous cell carcinomas.
    Hu YC; Lam KY; Tang JC; Srivastava G
    Mol Pathol; 1999 Dec; 52(6):353-6. PubMed ID: 10748870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation analysis of PTEN/MMAC1 in acute myeloid leukemia.
    Liu TC; Lin PM; Chang JG; Lee JP; Chen TP; Lin SF
    Am J Hematol; 2000 Apr; 63(4):170-5. PubMed ID: 10706759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues.
    Suzuki H; Freije D; Nusskern DR; Okami K; Cairns P; Sidransky D; Isaacs WB; Bova GS
    Cancer Res; 1998 Jan; 58(2):204-9. PubMed ID: 9443392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal structure and expression of PTEN/MMAC1 gene in human uterine cancers.
    Yaginuma Y; Yamashita T; Ishiya T; Morizaki A; Katoh Y; Takahashi T; Hayashi H; Ishikawa M
    Mol Carcinog; 2000 Feb; 27(2):110-6. PubMed ID: 10657903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational analysis of the tumour suppressor gene MMAC1/PTEN in malignant myeloid disorders.
    Aggerholm A; Grønbaek K; Guldberg P; Hokland P
    Eur J Haematol; 2000 Aug; 65(2):109-13. PubMed ID: 10966170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation analysis of the putative tumor suppressor PTEN/MMAC1 in human ovarian cancer.
    Yokomizo A; Tindall DJ; Hartmann L; Jenkins RB; Smith DI; Liu W
    Int J Oncol; 1998 Jul; 13(1):101-5. PubMed ID: 9625810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational analysis of the PTEN/MMAC1 gene in non-Hodgkin's lymphoma.
    Nakahara Y; Nagai H; Kinoshita T; Uchida T; Hatano S; Murate T; Saito H
    Leukemia; 1998 Aug; 12(8):1277-80. PubMed ID: 9697884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation analysis of PTEN/MMAC 1 in sporadic thyroid tumors.
    Hsieh MC; Lin SF; Shin SJ; Liu TC; Chang JG; Lee JP
    Kaohsiung J Med Sci; 2000 Jan; 16(1):9-12. PubMed ID: 10741010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas.
    Lin WM; Forgacs E; Warshal DP; Yeh IT; Martin JS; Ashfaq R; Muller CY
    Clin Cancer Res; 1998 Nov; 4(11):2577-83. PubMed ID: 9829719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the quality and frequency of mutations occurrence in PTEN gene in endometrial carcinomas and hyperplasias.
    Konopka B; Paszko Z; Janiec-Jankowska A; Goluda M
    Cancer Lett; 2002 Apr; 178(1):43-51. PubMed ID: 11849740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.